| Alkem Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 539523 |
NSE Symbol : ALKEM |
P/E(TTM) : 34.76 |
|
ISIN Demat : INE540L01014 |
Div & Yield% : 0.65 |
EPS(TTM) : 176.61 |
|
Book Value(₹) : 882.75 |
Market Cap(₹Cr) : 73,392.58 |
Face Value(₹) : 2.00 |
| Particulars | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 9,747.72 | 9,054.55 | 8,829.81 | 7,219.68 | 6,677.08 |
| Excise Duty | - | - | - | - | - |
| Net Sales | 9,747.72 | 9,054.55 | 8,829.81 | 7,219.68 | 6,677.08 |
| Other Income | 305.99 | 266.29 | 199.89 | 190.01 | 95.98 |
| Stock Adjustments | 71.31 | -257.73 | 360.90 | 301.29 | 33.69 |
| Total Income | 10,125.02 | 9,063.11 | 9,390.60 | 7,710.98 | 6,806.75 |
| EXPENDITURE : | |||||
| Raw Materials | 3,878.63 | 3,572.91 | 3,926.79 | 2,966.31 | 2,584.25 |
| Power and Fuel Cost | 123.85 | 126.32 | 129.53 | 100.12 | 106.08 |
| Other Manufacturing Expenses | 439.03 | 361.12 | 399.80 | 280.51 | 276.78 |
| Selling and Administration Expenses | 1,608.76 | 1,739.71 | 1,438.80 | 1,007.42 | 1,160.90 |
| Miscellaneous Expenses | 307.18 | 103.59 | 50.94 | 71.74 | 48.35 |
| Employee Benefit Expenses | 1,560.28 | 1,516.22 | 1,434.49 | 1,158.72 | 1,066.76 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 2,207.29 | 1,643.24 | 2,010.25 | 2,126.16 | 1,563.63 |
| Interest | 81.91 | 86.40 | 37.90 | 42.93 | 38.71 |
| Gross Profit | 2,125.38 | 1,556.84 | 1,972.35 | 2,083.23 | 1,524.92 |
| Depreciation | 244.35 | 229.85 | 218.98 | 198.93 | 186.84 |
| Profit Before Tax | 1,881.03 | 1,326.99 | 1,753.37 | 1,884.30 | 1,338.08 |
| Current Tax | 333.28 | 227.52 | 303.82 | 331.83 | 246.95 |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | -199.40 | -35.00 | -91.70 | -132.61 | -173.29 |
| Reported Net Profit | 1,747.15 | 1,134.47 | 1,541.25 | 1,685.08 | 1,264.42 |
| Extraordinary Items | -54.86 | -10.24 | 1.82 | 16.49 | 3.07 |
| Adjusted Net Profit | 1,802.01 | 1,144.71 | 1,539.43 | 1,668.59 | 1,261.35 |
| Adjustment below Net Profit | - | - | - | - | -73.21 |
| Profit/Loss Balance carried down | 7,431.77 | 6,823.39 | 5,700.62 | 4,350.32 | 3,517.81 |
| Statutory Appropriations | - | - | - | - | - |
| Appropriations | 538.04 | 526.09 | 418.48 | 334.78 | 358.70 |
| P & L Balance carried down | 8,640.88 | 7,431.77 | 6,823.39 | 5,700.62 | 4,350.32 |
| Dividend | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Equity Dividend (%) | 2,000.00 | 2,500.00 | 1,700.00 | 1,500.00 | 1,250.00 |
| Dividend Per Share(Rs) | 40.00 | 50.00 | 34.00 | 30.00 | 25.00 |
| Earnings Per Share-Unit Curr | 146.14 | 94.90 | 128.92 | 140.95 | 105.76 |
| Earnings Per Share(Adj)-Unit Curr | 146.14 | 94.90 | 128.92 | 140.95 | 105.76 |
| Book Value | 882.86 | 782.09 | 731.38 | 637.87 | 525.34 |
| Book Value(Adj)-Unit Curr | 882.86 | 782.09 | 731.38 | 637.87 | 525.34 |